| |JULY 20268TOP STORIESAI DRUG DISCOVERY GETS A BIG BOOST AS MANKIND MAKES A BOLD MOVENATIONAL DOCTORS' DAY: A POWERFUL REMINDER TO CARE FOR THE HEALERSNEW HORMONE PLANT PUTS CORONA REMEDIES AHEAD IN WOMEN'S HEALTHCAREAUROBINDO PHARMA'S LANNETT ACQUISITION MARKS NEW US CHAPTERCAN INDIA BECOME THE WORLD'S NEXT DRUG INNOVATION HUB?AI drug discovery is gaining momentum as pharmaceutical companies look for faster and more efficient ways to develop new medicines. The latest example comes from Mankind Pharma, which has entered into a strategic partnership with Denovo Sciences to strengthen its AI drug discovery capabilities. The collaboration reflects a growing trend in the pharmaceutical industry, where companies are increasingly using artificial intelligence to improve research, reduce development time, and identify promising drug candidates more efficiently. The partnership marks another step in Mankind Pharma's efforts to expand its innovation-driven research portfolio. PONational Doctors' Day is being celebrated across India today to honor the dedication and service of doctors who work day and night to save lives. This year's National Doctors' Day is not just about thanking the medical community but also about highlighting the challenges doctors face every day.The 2026 theme, "Behind the Mask: Who Heals the Healers?", puts the spotlight on the mental, emotional, and physical well-being of healthcare professionals who often put patients before themselves. Prime Minister Narendra Modi extended his greetings to doctors across the country, thanking them for their commitment to public health. PONew hormone plant has become the latest milestone for Corona Remedies as the company strengthens its position in women's healthcare with the commercial launch of a dedicated hormone manufacturing facility in Bhayla, Ahmedabad. The new hormone plant is expected to increase the company's hormone manufacturing capacity by around 20 percent while supporting its plans to serve both domestic and global markets. The facility has already secured EU-GMP approval, allowing the company to manufacture hormone-based medicines that meet international quality standards. The Ahmedabad-based pharmaceutical company said the new facility has been built to manufacture hormone products that require specialized production environments and strict contamination controls. POAurobindo Pharma's Lannett Acquisition has officially entered a new phase with the successful completion of its USD 250 million buyout of US-based Lannett Company. The deal, which was first announced in July 2025, has now crossed the final regulatory hurdle after receiving FTC approval, marking a major milestone in Aurobindo's expansion in the US pharmaceutical market.The Acquisition strengthens the company's manufacturing footprint, broadens its generic drugs portfolio, and supports its long-term growth strategy in the United States. The acquisition was completed through the company's wholly owned subsidiary, Aurobindo Pharma USA Inc. (APUSA), on June 29, 2026. Following the completion of the transaction, Lannett Company, Inc. has been converted into Lannett Company LLC, which will continue to operate as a wholly owned subsidiary of APUSA. POIndia has earned global recognition for its India pharma industry, but the next phase of growth could depend on a major shift. Experts believe the country's future lies in drug innovation through forward engineering, rather than relying mainly on generic medicines. While India continues to be known as the "Pharmacy of the World," industry leaders say it is time to move from copying existing drugs to creating new ones. This transition could help the India pharma industry strengthen its global position, build intellectual property, and unlock long-term growth. The discussion comes at a time when India remains one of the world's largest suppliers of affordable medicines. However, experts argue that manufacturing strength alone will not be enough to compete in the next era of global healthcare. Greater focus on pharmaceutical innovation and research and development is now seen as the key to sustained success. PO
< Page 7 | Page 9 >